RCUS

Arcus Biosciences, Inc.

Company with tickers: RCUS

CIK

1724521

CUSIP

03969F109

Shares Outstanding

125,773,162

Website

https://www.arcusbio.com

Investor Relations

https://investors.arcusbio.com/investors-and-media/default.aspx

13F Activity (30d)

3 filings 2 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Recent news

Date	Headline
2026-06-03	Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
2026-05-26	Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
2026-05-05	Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update
2026-04-21	Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates
2026-02-26	Arcus Biosciences to Participate in Two Upcoming Investor Conferences
2026-02-25	Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
2026-02-23	Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
2026-02-11	Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates
2026-01-07	Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
2025-12-18	Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Past events

Date	Event	Type
2026-06-09	Fireside Chat - Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-05-05	Arcus Biosciences First Quarter 2026 Earnings	Earnings call
2026-03-09	Fireside Chat - Leerink Global Healthcare Conference 2026	Conference
2026-02-25	Arcus Biosciences Full Year and Fourth Quarter 2025 Earnings	Earnings call
2026-01-14	Presentation - 44th Annual J.P. Morgan Healthcare Conference	Conference
2025-12-03	Fireside Chat - Citi's 2025 Global Healthcare Conference	Conference
2025-12-02	Fireside Chat - 8th Annual Evercore Healthcare Conference	Conference
2025-10-06	Arcus Biosciences 2025 Investor Event	Event
2025-09-10	Fireside Chat - Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-09-09	Fireside Chat - HC Wainwright 27th Annual Global Investment Conference	Conference
2025-09-03	Fireside Chat - Citi's 2025 Biopharma Back to School Conference	Conference
2025-08-06	Arcus Biosciences Second Quarter 2025 Financial Results (Release Only)	Event
2025-06-02	ASCO 2025: ARC-20 Cas + Cabo Data	Event
2025-05-06	Arcus Biosciences First Quarter 2025 Earnings	Earnings call
2025-03-13	Fireside Chat - Barclays 27th Annual Global Healthcare Conference	Conference
2025-03-12	Fireside Chat - Leerink Global Healthcare Conference 2025	Conference
2025-02-25	Arcus Biosciences Full Year and Fourth Quarter 2024 Financial Results (Release Only)	Event
2025-02-18	Updated ARC-20 Casdatifan Data Call	Event
2025-01-14	Presentation - 43rd Annual J.P. Morgan Healthcare Conference	Conference
2024-12-03	Fireside Chat - 7th Annual Evercore HealthCONx Conference	Conference
2024-11-06	Arcus Biosciences Third Quarter 2024 Earnings	Earnings call
2024-10-24	ARC-20 Phase 1b Casdatifan Data Call	Event
2024-09-19	Fireside Chat - 2024 Cantor Global Healthcare Conference	Conference
2024-09-04	Fireside Chat - Morgan Stanley 22nd Annual Global Healthcare Conference	Conference
2024-08-08	Arcus Biosciences Second Quarter 2024 Earnings and Financial Results	Earnings call

Source: https://investors.arcusbio.com/investors-and-media/default.aspx